Improvement programs may lead to improved Chlamydia trachomatis testing

July 16, 2020

The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.

Although the Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT), many clinicians still use urine NAAT to test for Chlamydia trachomatis in sexually active female patients under the age of 25.

A new report explored whether an improvement program could be beneficial in increasing the number of clinicians using the vaginal swab NAAT. The study ultimately discovered that the quality improvement program did, in fact, lead to significant increase in the use of vaginal swabs to test for C. trachomatis.

For details on this study and its findings, visit Contemporary Pediatrics.